Detalhe da pesquisa
1.
Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review.
Ann Oncol
; 28(12): 2943-2949, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28945877
2.
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials.
Ann Oncol
; 28(9): 2077-2085, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28430862
3.
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
Ann Oncol
; 27(8): 1386-422, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27380959
4.
Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer.
Ann Oncol
; 26(3): 535-41, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25515656
5.
BRCA2 gene: a candidate for clinical testing in familial colorectal cancer type X.
Clin Genet
; 87(6): 582-7, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24814045
6.
Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis in colorectal cancer patients with microsatellite instability tumors.
Tumour Biol
; 36(5): 3853-61, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25576161
7.
New challenges in kidney cancer management: integration of surgery and novel therapies.
Curr Treat Options Oncol
; 16(3): 337, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25782687
8.
Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients.
Ann Oncol
; 24(3): 655-61, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23104719
9.
Erlotinib versus pemetrexed for pretreated non-squamous non-small cell lung cancer patients in clinical practice.
Oncology
; 84(5): 255-64, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23428780
10.
Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials.
Clin Colorectal Cancer
; 22(2): 222-230, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36944559
11.
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.
Ann Oncol
; 23(5): 1190-1197, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21896539
12.
Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients.
Ann Oncol
; 23(7): 1750-6, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22052985
13.
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study).
Ann Oncol
; 23(7): 1919-25, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22156621
14.
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results.
Br J Cancer
; 105(1): 58-64, 2011 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21673685
15.
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010.
Ann Oncol
; 22 Suppl 5: v1-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21633049
16.
Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer.
Breast Cancer Res Treat
; 128(1): 127-36, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21465170
17.
Irinotecan-cetuximab-bevacizumab as a salvage treatment in heavily pretreated metastatic colorectal cancer patients: a retrospective observational study.
Chemotherapy
; 57(2): 138-44, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21447947
18.
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study.
ESMO Open
; 6(2): 100062, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33711671
19.
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.
Ann Oncol
; 21 Suppl 6: vi1-10, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20534623
20.
Celecoxib in a 12-year-old boy with familial adenomatous polyposis.
Int J Clin Pharmacol Ther
; 48(3): 230-2, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20197018